Saroglitazar
Saroglitazar (Lipaglyn) is a dual PPAR agonist with high potency, exhibiting EC50 values of 0.65 pM for PPARα and 3 nM for PPARγ. It is utilized in research for studying metabolic disorders, including dyslipidemia and type 2 diabetes, in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
495399-09-2
Product Name Alternative
Lipaglyn, PPARα, PPARγ, Saroglitazar
Field of Research
Metabolism Research, Molecular Biology, Pharmacology & Drug Discovery
Purity
98.49% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.55 mM) ; DMSO:22.5 mg/mL (51.19 mM)
Smiles
CCO[C@@H] (Cc1ccc (OCCn2c (C) ccc2-c2ccc (SC) cc2) cc1) C (O) =O
Molecular Formula
C25H29NO4S
Molecular Weight
439.57
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K4349402 1.0 µg DNA
Cmah sgRNA CRISPR Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details orb2892875 100 µL
Phospho-NF1 (Ser2515) Rabbit pAb, PE-Cy5 conjugated
Sign In for Pricing
View Details 
129147 100 µg
LMTK2 (Lemur Tyrosine Kinase 2, LMR2, Apoptosis-associated Tyrosine Kinase 2, AATYK2, Brain-enriched Kinase, BREK, hBREK, CDK5/p35-regulated Kinase, CPRK, FLJ46659, KIAA1079, Kinase/Phosphatase/Inhibitor 2, KPI2, KPI-2, Serine/threonine-protein Kinase LMTK2, Serine/Threonine-protein Kinase KPI-2)
Sign In for Pricing
View Details